Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31truefalse2023-04-01falseNo description of principal activity34trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09432750 2023-04-01 2024-03-31 09432750 2022-04-01 2023-03-31 09432750 2024-03-31 09432750 2023-03-31 09432750 c:Director1 2023-04-01 2024-03-31 09432750 d:Buildings 2023-04-01 2024-03-31 09432750 d:Buildings 2024-03-31 09432750 d:Buildings 2023-03-31 09432750 d:Buildings d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 09432750 d:PlantMachinery 2023-04-01 2024-03-31 09432750 d:PlantMachinery 2024-03-31 09432750 d:PlantMachinery 2023-03-31 09432750 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 09432750 d:MotorVehicles 2023-04-01 2024-03-31 09432750 d:MotorVehicles 2024-03-31 09432750 d:MotorVehicles 2023-03-31 09432750 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 09432750 d:FurnitureFittings 2023-04-01 2024-03-31 09432750 d:FurnitureFittings 2024-03-31 09432750 d:FurnitureFittings 2023-03-31 09432750 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 09432750 d:OfficeEquipment 2023-04-01 2024-03-31 09432750 d:OfficeEquipment 2024-03-31 09432750 d:OfficeEquipment 2023-03-31 09432750 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 09432750 d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 09432750 d:CurrentFinancialInstruments 2024-03-31 09432750 d:CurrentFinancialInstruments 2023-03-31 09432750 d:Non-currentFinancialInstruments 2024-03-31 09432750 d:Non-currentFinancialInstruments 2023-03-31 09432750 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 09432750 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 09432750 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 09432750 d:Non-currentFinancialInstruments d:AfterOneYear 2023-03-31 09432750 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2024-03-31 09432750 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2023-03-31 09432750 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2024-03-31 09432750 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2023-03-31 09432750 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2024-03-31 09432750 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2023-03-31 09432750 d:ShareCapital 2024-03-31 09432750 d:ShareCapital 2023-03-31 09432750 d:RetainedEarningsAccumulatedLosses 2024-03-31 09432750 d:RetainedEarningsAccumulatedLosses 2023-03-31 09432750 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2024-03-31 09432750 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2023-03-31 09432750 d:FinancialLiabilitiesFairValueThroughProfitOrLoss d:UnlistedNon-exchangeTraded 2024-03-31 09432750 d:FinancialLiabilitiesFairValueThroughProfitOrLoss d:UnlistedNon-exchangeTraded 2023-03-31 09432750 c:OrdinaryShareClass1 2023-04-01 2024-03-31 09432750 c:OrdinaryShareClass1 2024-03-31 09432750 c:OrdinaryShareClass1 2023-03-31 09432750 c:OrdinaryShareClass2 2023-04-01 2024-03-31 09432750 c:OrdinaryShareClass2 2024-03-31 09432750 c:OrdinaryShareClass2 2023-03-31 09432750 c:OrdinaryShareClass3 2023-04-01 2024-03-31 09432750 c:OrdinaryShareClass3 2024-03-31 09432750 c:OrdinaryShareClass3 2023-03-31 09432750 c:FRS102 2023-04-01 2024-03-31 09432750 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 09432750 c:FullAccounts 2023-04-01 2024-03-31 09432750 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 09432750 2 2023-04-01 2024-03-31 09432750 6 2023-04-01 2024-03-31 09432750 d:AcceleratedTaxDepreciationDeferredTax 2024-03-31 09432750 d:AcceleratedTaxDepreciationDeferredTax 2023-03-31 09432750 d:TaxLossesCarry-forwardsDeferredTax 2024-03-31 09432750 d:TaxLossesCarry-forwardsDeferredTax 2023-03-31 09432750 d:OtherDeferredTax 2024-03-31 09432750 d:OtherDeferredTax 2023-03-31 09432750 e:PoundSterling 2023-04-01 2024-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 09432750









THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
REGISTERED NUMBER: 09432750

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
808,794
813,460

Investments
 5 
108,379
114,455

  
917,173
927,915

Current assets
  

Debtors: amounts falling due within one year
 6 
1,038,693
851,822

Cash at bank and in hand
  
2,554
1,798

  
1,041,247
853,620

Creditors: amounts falling due within one year
 7 
(134,698)
(173,616)

Net current assets
  
 
 
906,549
 
 
680,004

Total assets less current liabilities
  
1,823,722
1,607,919

Creditors: amounts falling due after more than one year
 8 
(1,305,859)
(1,553,226)

Provisions for liabilities
  

Deferred tax
 11 
(23,564)
(8,080)

  
 
 
(23,564)
 
 
(8,080)

Net assets
  
494,299
46,613


Capital and reserves
  

Called up share capital 
 12 
100
100

Profit and loss account
  
494,199
46,513

  
494,299
46,613


Page 1

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
REGISTERED NUMBER: 09432750
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 12 July 2024.




P Jain
Director

The notes on pages 3 to 16 form part of these financial statements.

Page 2

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

The Company is a private company, limited by shares, incorporated and domiciled in England within the United Kingdom, registration number 09432750.  The Company's registered office is Sterling House, 71 Francis Road, Edgbaston, Birmingham, West Midlands, United Kingdom, B16 8SP.
The financial statements are presented in sterling which is the functional currency of the company and the financial statements are rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

Cash flow
Under Financial Reporting Standard 102, the company is exempt from the requirement to prepare a cash flow statement on the grounds that it qualifies as a small company.

 
2.2

Exemption from preparing consolidated financial statements

The Company, and the group headed by it, qualify as small as set out in section 383 of the Companies Act 2006 and the parent and group are considered eligible for the exemption to prepare consolidated accounts.

 
2.3

Going concern

The directors have prepared the accounts on a going concern basis.

Page 3

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.4

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Income and Retained Earnings within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

 
2.5

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Rental of equipment
Turnover from the rental of equipment is recognised when all the following conditions are satisfied:
-   the amount of turnover can be measured reliably;
-   it is probable that the Company will receive consideration due for the use of equipment;
-   the period of hire can be measured reliably; and 
-   the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.6

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.7

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 4

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.8

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.9

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 5

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)


2.10
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
20% straight line
Motor vehicles
-
Fixtures and fittings
-
20% straight line
Office equipment
-
20% straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.11

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in listed company shares, Gold Bullions and Cryptocurrencies are remeasured to market value at each Balance Sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.12

Debtors

Short term debtors are measured at transaction price, less any impairment.

 
2.13

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.14

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 6

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.15

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

Page 7

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.16

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities

Page 8

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)


2.16
Financial instruments (continued)

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Other financial instruments

Derivatives, including forward exchange contracts, futures contracts and interest rate swaps, are not classified as basic financial instruments. These are initially recognised at fair value on the date the derivative contract is entered into, with costs being charged to the profit or loss. They are subsequently measured at fair value with changes in the profit or loss.

Debt instruments that do not meet the conditions as set out in FRS 102 paragraph 11.9 are subsequently measured at fair value through the profit or loss. This recognition and measurement would also apply to financial instruments where the performance is evaluated on a fair value basis as with a documented risk management or investment strategy.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Page 9

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

3.


Employees




The average monthly number of employees, including directors, during the year was 3 (2023 - 4).


4.


Tangible fixed assets





Freehold property
Plant and machinery
Motor vehicles
Fixtures and fittings
Office equipment

£
£
£
£
£



Cost or valuation


At 1 April 2023
756,841
220,558
22,595
197,794
35,665


Additions
-
31,816
-
272
772



At 31 March 2024

756,841
252,374
22,595
198,066
36,437



Depreciation


At 1 April 2023
14,290
177,866
2,636
193,874
31,330


Charge for the year on owned assets
6,252
22,299
4,519
1,954
2,499



At 31 March 2024

20,542
200,165
7,155
195,828
33,829



Net book value



At 31 March 2024
736,299
52,209
15,440
2,238
2,608



At 31 March 2023
742,550
42,692
19,959
3,921
4,335
Page 10

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

           4.Tangible fixed assets (continued)


Total

£



Cost or valuation


At 1 April 2023
1,233,453


Additions
32,860



At 31 March 2024

1,266,313



Depreciation


At 1 April 2023
419,996


Charge for the year on owned assets
37,523



At 31 March 2024

457,519



Net book value



At 31 March 2024
808,794



At 31 March 2023
813,457

Page 11

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

5.


Fixed asset investments





Investments in subsidiary companies
Listed investments
Other fixed asset investments
Total

£
£
£
£



Cost or valuation


At 1 April 2023
100
9,078
105,275
114,453


Disposals
-
-
(35,145)
(35,145)


Revaluations
-
4,491
24,580
29,071



At 31 March 2024
100
13,569
94,710
108,379




The investment in subsidiary undertakings relate to a 100% holding of Sutton Dental and Implant Clinic Limited. 
The registered office of the subsidiary undertaking is the same as the registered office of the parent company, being Sterling House, 71 Francis Road, Edgbaston, Birmingham, West Midlands, United Kingdom, B16 8SP.


6.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
1,038,660
851,792

Other debtors
33
30

1,038,693
851,822


Page 12

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loans
80,614
68,121

Other creditors
52,974
104,506

Accruals and deferred income
1,110
989

134,698
173,616


Bank loans of £70,614 (2023 - £58,120) are secured by legal charge over the freehold property known as 60 Birmingham Road,  Sutton Coldfield Birmingham, held by Barclays Bank PLC. The loan is also secured by a debenture incorporating a fixed and floating charge. In addition the loan is subject to a cross guarantee from its subsidiary company.


8.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loans
1,305,859
1,553,226

1,305,859
1,553,226


Bank loans of £1,292,526 (2023 - £1,529,890) are secured by legal charge over the freehold property known as 60 Birmingham Road,  Sutton Coldfield Birmingham, held by Barclays Bank PLC. The loan is also secured by a debenture incorporating a fixed and floating charge. In addition the loan is subject to a cross guarantee from its subsidiary company.

Page 13

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

9.


Loans


Analysis of the maturity of loans is given below:


2024
2023
£
£

Amounts falling due within one year

Bank loans
80,614
68,121


80,614
68,121

Amounts falling due 1-2 years

Bank loans
80,614
68,121


80,614
68,121

Amounts falling due 2-5 years

Bank loans
215,176
187,696


215,176
187,696

Amounts falling due after more than 5 years

Bank loans
1,010,069
1,297,406

1,010,069
1,297,406

1,386,473
1,621,344


Within amounts falling due after more than 5 years £1,010,069 (2023 - £1,297,406) is repayable by installments.

Page 14

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

10.


Financial instruments

2024
2023
£
£

Financial assets


Financial assets measured at fair value through profit or loss
108,280
114,353

Financial assets measured at undiscounted amount receiveable
1,041,247
853,620

1,149,527
967,973


Financial liabilities


Financial liabilities measured at amortised cost
1,386,473
1,621,344

Financial liabilities measured at undiscounted amount payable
1,110
988

1,387,583
1,622,332


Financial assets measured at fair value through profit or loss comprise investments in listed shares and investments in Cryptocurrency and gold bullions.
Financial assets measured at undiscounted amount receivable comprise bank and cash balances and amounts owed by group undertakings.
Financial liabilities measured at amortised cost comprise bank loans.
Financial liabilities measured at undiscounted amount payable comprise accruals and amounts owed to group undertakings.


11.


Deferred taxation




2024


£






At beginning of year
(8,080)


Charged to profit or loss
(15,484)



At end of year
(23,564)

Page 15

 
THE DENTAL CARE PARTNERSHIP (BIRMINGHAM) HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
 
11.Deferred taxation (continued)

The provision for deferred taxation is made up as follows:

2024
2023
£
£


Accelerated capital allowances
(11,314)
(7,160)

Tax losses carried forward
2,342
110

Revaluation of investments
(14,592)
(1,030)

(23,564)
(8,080)


12.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



70 (2023 - 70) Ordinary shares of £1.00 each
70
70
15 (2023 - 15) Ordinary 'A' shares of £1.00 each
15
15
15 (2023 - 15) Ordinary 'B' shares of £1.00 each
15
15

100

100



13.


Related party transactions

During the year the company made a loan to a wholly owned subsidiary. The balance owed from the subsidiary company as at 31 March 2024 was £1,038,660 (2023 - £851,792).
During the year the company made loans to shareholders and at the balance sheet date amounts due to shareholders was £Nil (2023 - £21,937).
As at 31 March 2024, amounts of £52,977 (2023 - £82,568) were due to directors of the company.  No interest has been charged and amounts are repayable on demand.

 
Page 16